Combined Immune Therapy Examined for Early Type 1 Diabetes

1 source1 article First seen 14 hours ago Updated 14 hours ago United States Truth score 38

Save Like Comments Compare coverage

Summary

Two case reports and several ongoing clinical trials highlight the potential of combination immune-modulating therapies to preserve beta-cell function in T1D.

Description from Medscape.

Who is covering this

Medscape Center Factuality: Mostly factual US 14 hours ago
Combined Immune Therapy Examined for Early Type 1 Diabetes
Two case reports and several ongoing clinical trials highlight the potential of combination immune-modulating therapies to preserve beta-cell function in T1D.

Comments

Comments need JavaScript.

Truth score

38/100Weakly supported

Independent outlets: 1
Source reliability: 65/100
Sides of the spectrum covering it: 1/3
Propaganda risk: 0/100

How well the story is corroborated by independent, reliable outlets across the spectrum. Not a fact-check of each claim. How the truth score works

Coverage by lean

Centre 100%100%

Left: 0
Centre: 1
Right: 0
Not rated: 0

How lean is counted

Source quality

Average reliability: 65/100 (Mostly factual)
Low-credibility outlets: 0%
State media: 0%
Opinion pieces: 0%

Where ratings come from

Where the coverage comes from

United States1

Filter the stories

Sources Ratings and details

Combined Immune Therapy Examined for Early Type 1 Diabetes

Summary

Who is covering this

Comments